NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)

The summary for the NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required): (Reissue of PAR-18-618) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only SBIR Phase II and Fast-Track applications are supported under this program. SBIR Phase I applications are only accepted as part of a Fast-track application.
Federal Grant Title: NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-21-266
Type of Funding: Grant
CFDA Numbers: 93.853
CFDA Descriptions: Information not provided
Current Application Deadline: April 5th, 2024
Original Application Deadline: April 5th, 2024
Posted Date: July 15th, 2021
Creation Date: July 15th, 2021
Archive Date: May 11th, 2024
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: January 21st, 2022
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement
Grant Announcement Contact
NIH OER Webmaster
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial No...
Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Cli...
Using Multimodal Biomarkers to Differentially Diagnose ADRDs for Clinical Trials (U19 Clin...
NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 C...
NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
NINDS Institutional Center Core Grants to Support Neuroscience Research
Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health
NIH Administrative Supplements to Recover Losses due to Hurricanes Fiona and Ian Under the...
Biological Testing Facility (X01 Clinical Trial Not Allowed)
Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in th...
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording an... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2023